Pharma Journalist - Page 724 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Attune Medical Receives US FDA’s clearance for new EnsoETM

Novaliq Enrols Dry Eye disease patients in its SEECASE Phase 2 Clinical Trial of NOV03

4 key questions in new experimental technologies answered at SMI’s Drug Discovery Conference 2018

Mitochondrial organizations to create Mitochondrial Care Network

Medivir AB to initiate phase 1 clinical trials for MIV-818 in 2018

Christian Pangratz appointed CEO of sterna biologicals

Acercus Entitled To Commercialize UriVarx in Canada